Fort Sheridan Advisors LLC Has $44.27 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Fort Sheridan Advisors LLC reduced its stake in CME Group Inc. (NASDAQ:CMEGet Rating) by 2.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 186,124 shares of the financial services provider’s stock after selling 4,285 shares during the period. CME Group accounts for 13.0% of Fort Sheridan Advisors LLC’s portfolio, making the stock its largest position. Fort Sheridan Advisors LLC owned approximately 0.05% of CME Group worth $44,271,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. CWM LLC bought a new position in shares of CME Group during the fourth quarter valued at approximately $491,000. Qube Research & Technologies Ltd increased its stake in shares of CME Group by 186.5% during the fourth quarter. Qube Research & Technologies Ltd now owns 101,641 shares of the financial services provider’s stock valued at $23,221,000 after purchasing an additional 66,161 shares in the last quarter. FDx Advisors Inc. increased its stake in shares of CME Group by 9.0% during the fourth quarter. FDx Advisors Inc. now owns 1,680 shares of the financial services provider’s stock valued at $384,000 after purchasing an additional 139 shares in the last quarter. AGF Investments Inc. increased its stake in shares of CME Group by 49.6% during the fourth quarter. AGF Investments Inc. now owns 1,496 shares of the financial services provider’s stock valued at $342,000 after purchasing an additional 496 shares in the last quarter. Finally, Fifth Third Bancorp increased its stake in shares of CME Group by 1.2% during the fourth quarter. Fifth Third Bancorp now owns 110,266 shares of the financial services provider’s stock valued at $25,191,000 after purchasing an additional 1,298 shares in the last quarter. 86.71% of the stock is owned by institutional investors.

CME Group Stock Up 1.1 %

CME opened at $202.15 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $185.79 and a fifty-two week high of $256.94. The firm’s fifty day moving average is $202.69 and its 200 day moving average is $219.59. The stock has a market cap of $72.66 billion, a price-to-earnings ratio of 25.08, a price-to-earnings-growth ratio of 3.22 and a beta of 0.40.

CME Group (NASDAQ:CMEGet Rating) last released its earnings results on Wednesday, July 27th. The financial services provider reported $1.97 earnings per share for the quarter, beating analysts’ consensus estimates of $1.89 by $0.08. CME Group had a net margin of 60.43% and a return on equity of 9.65%. The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.25 billion. During the same quarter in the previous year, the company earned $1.64 EPS. CME Group’s revenue for the quarter was up 4.9% on a year-over-year basis. On average, sell-side analysts forecast that CME Group Inc. will post 7.97 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 27th. Investors of record on Friday, September 9th will be paid a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.98%. The ex-dividend date is Thursday, September 8th. CME Group’s dividend payout ratio (DPR) is 49.63%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Citigroup raised their target price on shares of CME Group from $275.00 to $280.00 in a research note on Thursday, April 28th. Credit Suisse Group reduced their price target on shares of CME Group from $218.00 to $216.00 and set a “neutral” rating for the company in a research report on Wednesday. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $210.00 to $213.00 and gave the company a “hold” rating in a research report on Wednesday, July 13th. Oppenheimer raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $223.00 price target for the company in a research report on Wednesday, May 25th. Finally, Argus upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Monday, May 16th. One analyst has rated the stock with a sell rating, nine have given a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $237.67.

About CME Group

(Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.